7LY9 image
Deposition Date 2021-03-06
Release Date 2021-08-18
Last Version Date 2025-05-14
Entry Detail
PDB ID:
7LY9
Title:
Cryo-EM structure of 2909 Fab in complex with 3BNC117 Fab and CAP256.wk34.c80 SOSIP.RnS2 N160K HIV-1 Env trimer
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
3.91 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:3BNC117 Heavy Chain
Chain IDs:D (auth: B), H (auth: E), L (auth: A)
Chain Length:226
Number of Molecules:3
Biological Source:Homo sapiens
Protein Blast
Polymer Type:polypeptide(L)
Molecule:3BNC117 Light Chain
Chain IDs:E (auth: C), I, M
Chain Length:206
Number of Molecules:3
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp41
Gene (Uniprot):env
Chain IDs:F, J, N
Chain Length:154
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp120
Gene (Uniprot):env
Chain IDs:C (auth: G), G (auth: D), K
Chain Length:471
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Protein Blast
Polymer Type:polypeptide(L)
Molecule:2909 Heavy Chain
Chain IDs:B (auth: H)
Chain Length:231
Number of Molecules:1
Biological Source:Homo sapiens
Protein Blast
Polymer Type:polypeptide(L)
Molecule:2909 Light Chain
Chain IDs:A (auth: L)
Chain Length:211
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces.
Nat Commun 12 6470 6470 (2021)
PMID: 34753907 DOI: 10.1038/s41467-021-26579-z

Abstact

Antibody-Framework-to-Antigen Distance (AFAD) - the distance between the body of an antibody and a protein antigen - is an important parameter governing antibody recognition. Here, we quantify AFAD for ~2,000 non-redundant antibody-protein-antigen complexes in the Protein Data Bank. AFADs showed a gaussian distribution with mean of 16.3 Å and standard deviation (σ) of 2.4 Å. Notably, antibody-antigen complexes with extended AFADs (>3σ) were exclusively human immunodeficiency virus-type 1 (HIV-1)-neutralizing antibodies. High correlation (R2 = 0.8110) was observed between AFADs and glycan coverage, as assessed by molecular dynamics simulations of the HIV-1-envelope trimer. Especially long AFADs were observed for antibodies targeting the glycosylated trimer apex, and we tested the impact of introducing an apex-glycan hole (N160K); the cryo-EM structure of the glycan hole-targeting HIV-1-neutralizing antibody 2909 in complex with an N160K-envelope trimer revealed a substantially shorter AFAD. Overall, extended AFADs exclusively recognized densely glycosylated surfaces, with the introduction of a glycan hole enabling closer recognition.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback